NAFDAC's Adeyeye Calls for Local Vaccine Manufacturing Support
Prof. Mojisola Adeyeye, the Director General of NAFDAC, announced that the absence of local vaccine manufacturing capacity is delaying the agency's achievement of World Health Organisation (WHO) Maturity Level 4 certification for vaccine lot release. Speaking at the 8th Nigeria Pharma Manufacturers’ Expo in Lagos, she highlighted that Nigeria has made significant progress in its medicines and vaccines regulatory system, having met eight of the nine necessary functions for WHO certification.
The remaining requirement is local vaccine production, which is essential for achieving vaccine lot release. Adeyeye called on international development partners to assist in establishing fill-and-finish modular vaccine manufacturing facilities in Nigeria.
She also commended President Bola Ahmed Tinubu for the 2024 Executive Order on local pharmaceutical manufacturing, which has provided critical incentives to manufacturers. Adeyeye emphasized the need to rebuild Nigeria's vaccine manufacturing capacity to enhance medicine security and reduce reliance on imports.
Plus234Feed summary based on reporting from Leadership Newspaper. Read the original report below.
Read full article
Continue on Leadership Newspaper
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
NAFDAC's Adeyeye Calls for Global Support in Vaccine Production
NAFDAC DG Links Counterfeit Medicine Crisis to Gaps
NAFDAC Addresses Fake Product Concerns in Nigeria
NAFDAC Reports 70% Cut in Drug Imports, Boosts Local Manufacturing
NAFDAC Alerts on Local Production of Counterfeit Goods
Nigeria Completes Equity Commitment for Vaccine Production
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
